BlackRock’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
Other funds holding BVS
EWM
JIC
NCM
RA
BlackRock's BVS Position: Q2 2026 in Review
BlackRock increased its Bioventus (BVS) stake by 9.6% in Q2 2026, buying an estimated $2.89M and bringing the position to 3,435,914 shares worth $32.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2946.
BlackRock first reported a position in BVS in Q1 2021 and has held it in 22 quarters since. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.
- BlackRock held 3,435,914 shares of Bioventus worth $32.4M as of Q2 2026.
- BlackRock bought 302,373 Bioventus shares in Q2 2026, an estimated $2.89M.
- Bioventus made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2946 holding.
- BlackRock first reported a position in Bioventus in Q1 2021 and has held it in 22 quarters since.
- 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.